 | A1BSY | Name: | (3S)-N~1~-(5-cyano-2-methoxyphenyl)piperidine-1,3-dicarboxamide | Formula: | C15 H18 N4 O3 | SMILES: | O=C(Nc1cc(C#N)ccc1OC)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C15H18N4O3/c1-22-13-5-4-10(8-16)7-12(13)18-15(21)19-6-2-3-11(9-19)14(17)20/h4-5,7,11H,2-3,6,9H2,1H3,(H2,17,20)(H,18,21)/t11-/m0/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-N~1~-(5-cyano-2-methoxyphenyl)piperidine-1,3-dicarboxamide |
|
 | A1BSZ | Name: | (3S)-1-[(5-bromo-2-methoxypyridin-3-yl)acetyl]piperidine-3-carboxamide | Formula: | C14 H18 Br N3 O3 | SMILES: | O=C(Cc1cc(Br)cnc1OC)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C14H18BrN3O3/c1-21-14-10(5-11(15)7-17-14)6-12(19)18-4-2-3-9(8-18)13(16)20/h5,7,9H,2-4,6,8H2,1H3,(H2,16,20)/t9-/m0/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(5-bromo-2-methoxypyridin-3-yl)acetyl]piperidine-3-carboxamide |
|
 | A1BTB | Name: | (3S)-N~1~-(3-methylphenyl)-N~1~-[2-oxo-2-(piperidin-1-yl)ethyl]piperidine-1,3-dicarboxamide | Formula: | C21 H30 N4 O3 | SMILES: | O=C(N(CC(=O)N1CCCCC1)c1cc(C)ccc1)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C21H30N4O3/c1-16-7-5-9-18(13-16)25(15-19(26)23-10-3-2-4-11-23)21(28)24-12-6-8-17(14-24)20(22)27/h5,7,9,13,17H,2-4,6,8,10-12,14-15H2,1H3,(H2,22,27)/t17-/m0/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-N~1~-(3-methylphenyl)-N~1~-[2-oxo-2-(piperidin-1-yl)ethyl]piperidine-1,3-dicarboxamide |
|
 | A1BTC | Name: | (2S)-4-[(2-methoxyphenyl)acetyl]piperazine-2-carboxamide | Formula: | C14 H19 N3 O3 | SMILES: | O=C(Cc1ccccc1OC)N1CC(NCC1)C(N)=O | InChi: | InChI=1S/C14H19N3O3/c1-20-12-5-3-2-4-10(12)8-13(18)17-7-6-16-11(9-17)14(15)19/h2-5,11,16H,6-9H2,1H3,(H2,15,19)/t11-/m0/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (2S)-4-[(2-methoxyphenyl)acetyl]piperazine-2-carboxamide |
|
 | A1BTF | Name: | 4-methyl-N~1~-(2-methylphenyl)benzene-1,3-dicarboxamide | Formula: | C16 H16 N2 O2 | SMILES: | O=C(Nc1ccccc1C)c1ccc(C)c(c1)C(N)=O | InChi: | InChI=1S/C16H16N2O2/c1-10-7-8-12(9-13(10)15(17)19)16(20)18-14-6-4-3-5-11(14)2/h3-9H,1-2H3,(H2,17,19)(H,18,20) | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | 4-methyl-N~1~-(2-methylphenyl)benzene-1,3-dicarboxamide |
|
 | 3CN | Name: | 3-AMINOPROPANE | Formula: | C3 H9 N | SMILES: | NCCC | InChi: | InChI=1S/C3H9N/c1-2-3-4/h2-4H2,1H3 | Definition date: | 1999-11-01 | Last modified: | 2025-02-19 | Identifier: | propan-1-amine |
|
 | MYR | Name: | MYRISTIC ACID | Formula: | C14 H28 O2 | SMILES: | O=C(O)CCCCCCCCCCCCC | InChi: | InChI=1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16) | Definition date: | 1999-07-07 | Last modified: | 2025-02-18 | Identifier: | tetradecanoic acid |
|
 | C2K | Name: | (3~{S})-19-chloranyl-~{N}-(1-cyanocyclopropyl)-5-oxidanylidene-9-(trifluoromethyl)-12,17-dioxa-4-azatricyclo[16.2.2.0^{6,11}]docosa-1(21),6(11),7,9,18(22),19-hexaene-3-carboxamide | Formula: | C25 H23 Cl F3 N3 O4 | SMILES: | FC(F)(F)c1ccc2C(=O)N[CH](Cc3ccc(OCCCCOc2c1)c(Cl)c3)C(=O)NC4(CC4)C#N | InChi: | InChI=1S/C25H23ClF3N3O4/c26-18-11-15-3-6-20(18)35-9-1-2-10-36-21-13-16(25(27,28)29)4-5-17(21)22(33)31-19(12-15)23(34)32-24(14-30)7-8-24/h3-6,11,13,19H,1-2,7-10,12H2,(H,31,33)(H,32,34)/t19-/m0/s1 | Definition date: | 2017-11-08 | Last modified: | 2025-02-18 | Release date: | 2018-04-11 | Identifier: | (3~{S})-19-chloranyl-~{N}-(1-cyanocyclopropyl)-5-oxidanylidene-9-(trifluoromethyl)-12,17-dioxa-4-azatricyclo[16.2.2.0^{6,11}]docosa-1(21),6(11),7,9,18(22),19-hexaene-3-carboxamide |
|
 | A1D7R | Name: | (2~{S})-2-azanyl-3-[6-(3-methylbut-2-enyl)-1~{H}-indol-3-yl]propanoic acid | Formula: | C16 H20 N2 O2 | SMILES: | CC(C)=CCc1ccc2c(C[CH](N)C(O)=O)c[nH]c2c1 | InChi: | InChI=1S/C16H20N2O2/c1-10(2)3-4-11-5-6-13-12(8-14(17)16(19)20)9-18-15(13)7-11/h3,5-7,9,14,18H,4,8,17H2,1-2H3,(H,19,20)/t14-/m0/s1 | Synonyms: | 6-dimethylallyl-L-tryptophan | Definition date: | 2024-04-12 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | (2~{S})-2-azanyl-3-[6-(3-methylbut-2-enyl)-1~{H}-indol-3-yl]propanoic acid |
|
 | A1D7V | Name: | (~{N}~{Z})-~{N}-[2-[6-(3-methylbut-2-enyl)-1~{H}-indol-3-yl]ethylidene]hydroxylamine | Formula: | C15 H18 N2 O | SMILES: | CC(C)=CCc1ccc2c(CC=NO)c[nH]c2c1 | InChi: | InChI=1S/C15H18N2O/c1-11(2)3-4-12-5-6-14-13(7-8-17-18)10-16-15(14)9-12/h3,5-6,8-10,16,18H,4,7H2,1-2H3/b17-8- | Definition date: | 2024-04-12 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | (~{N}~{Z})-~{N}-[2-[6-(3-methylbut-2-enyl)-1~{H}-indol-3-yl]ethylidene]hydroxylamine |
|
 | A1EEE | Name: | (6~{S},9~{a}~{S})-6-(3-azidopropyl)-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-~{N}-[4,4,4-tris(fluoranyl)butyl]-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide | Formula: | C26 H30 F3 N7 O3 | SMILES: | FC(F)(F)CCCNC(=O)N1CCC(=O)N2[CH]1CN(Cc3cccc4ccccc34)C(=O)[CH]2CCCN=[N+]=[N-] | InChi: | InChI=1S/C26H30F3N7O3/c27-26(28,29)12-5-13-31-25(39)35-15-11-23(37)36-21(10-4-14-32-33-30)24(38)34(17-22(35)36)16-19-8-3-7-18-6-1-2-9-20(18)19/h1-3,6-9,21-22H,4-5,10-17H2,(H,31,39)/t21-,22+/m0/s1 | Definition date: | 2024-10-20 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | (6~{S},9~{a}~{S})-6-(3-azidopropyl)-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-~{N}-[4,4,4-tris(fluoranyl)butyl]-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide |
|
 | A1EEF | Name: | (6~{S},9~{a}~{S})-6-(1~{H}-imidazol-5-ylmethyl)-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-~{N}-(phenylmethyl)-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide | Formula: | C30 H30 N6 O3 | SMILES: | O=C1CCN([CH]2CN(Cc3cccc4ccccc34)C(=O)[CH](Cc5[nH]cnc5)N12)C(=O)NCc6ccccc6 | InChi: | InChI=1S/C30H30N6O3/c37-28-13-14-35(30(39)32-16-21-7-2-1-3-8-21)27-19-34(18-23-11-6-10-22-9-4-5-12-25(22)23)29(38)26(36(27)28)15-24-17-31-20-33-24/h1-12,17,20,26-27H,13-16,18-19H2,(H,31,33)(H,32,39)/t26-,27+/m0/s1 | Definition date: | 2024-10-20 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | (6~{S},9~{a}~{S})-6-(1~{H}-imidazol-5-ylmethyl)-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-~{N}-(phenylmethyl)-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide |
|
 | A1EEK | Name: | (6~{S},9~{a}~{S})-6-[(2~{S})-butan-2-yl]-8-[(4-methoxynaphthalen-1-yl)methyl]-4,7-bis(oxidanylidene)-~{N}-[4,4,4-tris(fluoranyl)butyl]-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide | Formula: | C28 H35 F3 N4 O4 | SMILES: | CC[CH](C)[CH]1N2[CH](CN(Cc3ccc(OC)c4ccccc34)C1=O)N(CCC2=O)C(=O)NCCCC(F)(F)F | InChi: | InChI=1S/C28H35F3N4O4/c1-4-18(2)25-26(37)33(16-19-10-11-22(39-3)21-9-6-5-8-20(19)21)17-23-34(15-12-24(36)35(23)25)27(38)32-14-7-13-28(29,30)31/h5-6,8-11,18,23,25H,4,7,12-17H2,1-3H3,(H,32,38)/t18-,23+,25-/m0/s1 | Definition date: | 2024-10-22 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | (6~{S},9~{a}~{S})-6-[(2~{S})-butan-2-yl]-8-[(4-methoxynaphthalen-1-yl)methyl]-4,7-bis(oxidanylidene)-~{N}-[4,4,4-tris(fluoranyl)butyl]-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide |
|
 | A1H3Y | Name: | 2-(5-phenylmethoxy-1~{H}-indol-3-yl)ethanol | Formula: | C17 H17 N O2 | SMILES: | OCCc1c[nH]c2ccc(OCc3ccccc3)cc12 | InChi: | InChI=1S/C17H17NO2/c19-9-8-14-11-18-17-7-6-15(10-16(14)17)20-12-13-4-2-1-3-5-13/h1-7,10-11,18-19H,8-9,12H2 | Definition date: | 2024-02-08 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | 2-(5-phenylmethoxy-1~{H}-indol-3-yl)ethanol |
|
 | A1H3Z | Name: | 4-(5-phenylmethoxy-1~{H}-indol-3-yl)butan-2-one | Formula: | C19 H19 N O2 | SMILES: | CC(=O)CCc1c[nH]c2ccc(OCc3ccccc3)cc12 | InChi: | InChI=1S/C19H19NO2/c1-14(21)7-8-16-12-20-19-10-9-17(11-18(16)19)22-13-15-5-3-2-4-6-15/h2-6,9-12,20H,7-8,13H2,1H3 | Definition date: | 2024-02-08 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | 4-(5-phenylmethoxy-1~{H}-indol-3-yl)butan-2-one |
|
 | PAB | Name: | 4-AMINOBENZOIC ACID | Formula: | C7 H7 N O2 | SMILES: | O=C(O)c1ccc(N)cc1 | InChi: | InChI=1S/C7H7NO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,8H2,(H,9,10) | Definition date: | 1999-07-08 | Last modified: | 2025-02-14 | Identifier: | 4-aminobenzoic acid |
|
 | W5T | Name: | ~{N}-[[1-(4-chlorophenyl)sulfonylpiperidin-4-yl]methyl]ethanamide | Formula: | C14 H19 Cl N2 O3 S | SMILES: | CC(=O)NCC1CCN(CC1)[S](=O)(=O)c2ccc(Cl)cc2 | InChi: | InChI=1S/C14H19ClN2O3S/c1-11(18)16-10-12-6-8-17(9-7-12)21(19,20)14-4-2-13(15)3-5-14/h2-5,12H,6-10H2,1H3,(H,16,18) | Definition date: | 2023-09-25 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | ~{N}-[[1-(4-chlorophenyl)sulfonylpiperidin-4-yl]methyl]ethanamide |
|
 | A1IHA | Name: | 2-(1-adamantyl)-~{N}-[2-[2-[2-oxidanylidene-2-[7-[1-(phenylmethyl)-5-[(2,4,6-trimethylphenyl)sulfonylamino]benzimidazol-2-yl]heptylamino]ethoxy]ethoxy]ethyl]ethanamide | Formula: | C48 H65 N5 O6 S | SMILES: | Cc1cc(C)c(c(C)c1)[S](=O)(=O)Nc2ccc3n(Cc4ccccc4)c(CCCCCCCNC(=O)COCCOCCNC(=O)CC56CC7CC(CC(C7)C5)C6)nc3c2 | InChi: | InChI=1S/C48H65N5O6S/c1-34-22-35(2)47(36(3)23-34)60(56,57)52-41-15-16-43-42(27-41)51-44(53(43)32-37-12-8-7-9-13-37)14-10-5-4-6-11-17-49-46(55)33-59-21-20-58-19-18-50-45(54)31-48-28-38-24-39(29-48)26-40(25-38)30-48/h7-9,12-13,15-16,22-23,27,38-40,52H,4-6,10-11,14,17-21,24-26,28-33H2,1-3H3,(H,49,55)(H,50,54)/t38?,39?,40?,48- | Definition date: | 2024-07-05 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | 2-(1-adamantyl)-~{N}-[2-[2-[2-oxidanylidene-2-[7-[1-(phenylmethyl)-5-[(2,4,6-trimethylphenyl)sulfonylamino]benzimidazol-2-yl]heptylamino]ethoxy]ethoxy]ethyl]ethanamide |
|
 | A1IHB | Name: | 2-(1-adamantyl)-~{N}-[7-[1-(phenylmethyl)-5-[(2,4,6-trimethylphenyl)sulfonylamino]benzimidazol-2-yl]heptyl]ethanamide | Formula: | C42 H54 N4 O3 S | SMILES: | Cc1cc(C)c(c(C)c1)[S](=O)(=O)Nc2ccc3n(Cc4ccccc4)c(CCCCCCCNC(=O)CC56CC7CC(CC(C7)C5)C6)nc3c2 | InChi: | InChI=1S/C42H54N4O3S/c1-29-18-30(2)41(31(3)19-29)50(48,49)45-36-15-16-38-37(23-36)44-39(46(38)28-32-12-8-7-9-13-32)14-10-5-4-6-11-17-43-40(47)27-42-24-33-20-34(25-42)22-35(21-33)26-42/h7-9,12-13,15-16,18-19,23,33-35,45H,4-6,10-11,14,17,20-22,24-28H2,1-3H3,(H,43,47)/t33?,34?,35?,42- | Definition date: | 2024-07-05 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | 2-(1-adamantyl)-~{N}-[7-[1-(phenylmethyl)-5-[(2,4,6-trimethylphenyl)sulfonylamino]benzimidazol-2-yl]heptyl]ethanamide |
|
 | A1ITA | Name: | 5-(methylamino)-6-(3-methylimidazo[4,5-c]pyridin-7-yl)-3-[(4-morpholin-4-ylphenyl)amino]pyrazine-2-carboxamide | Formula: | C23 H25 N9 O2 | SMILES: | CNc1nc(Nc2ccc(cc2)N3CCOCC3)c(nc1c4cncc5n(C)cnc45)C(N)=O | InChi: | InChI=1S/C23H25N9O2/c1-25-22-19(16-11-26-12-17-18(16)27-13-31(17)2)29-20(21(24)33)23(30-22)28-14-3-5-15(6-4-14)32-7-9-34-10-8-32/h3-6,11-13H,7-10H2,1-2H3,(H2,24,33)(H2,25,28,30) | Definition date: | 2024-10-29 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | 5-(methylamino)-6-(3-methylimidazo[4,5-c]pyridin-7-yl)-3-[(4-morpholin-4-ylphenyl)amino]pyrazine-2-carboxamide |
|
 | A1ITB | Name: | 5-cyclopropyl-6-(3-methylimidazo[4,5-c]pyridin-7-yl)-3-[[3-methyl-1-[2,2,2-tris(fluoranyl)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide | Formula: | C21 H20 F3 N9 O | SMILES: | Cn1cnc2c1cncc2c3nc(C(N)=O)c(Nc4cn(CC(F)(F)F)nc4C)nc3C5CC5 | InChi: | InChI=1S/C21H20F3N9O/c1-10-13(7-33(31-10)8-21(22,23)24)28-20-18(19(25)34)29-17(15(30-20)11-3-4-11)12-5-26-6-14-16(12)27-9-32(14)2/h5-7,9,11H,3-4,8H2,1-2H3,(H2,25,34)(H,28,30) | Definition date: | 2024-10-29 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | 5-cyclopropyl-6-(3-methylimidazo[4,5-c]pyridin-7-yl)-3-[[3-methyl-1-[2,2,2-tris(fluoranyl)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide |
|
 | A1ITC | Name: | 6-(1-methylbenzimidazol-4-yl)-3-[(4-morpholin-4-ylphenyl)amino]pyrazine-2-carboxamide | Formula: | C23 H23 N7 O2 | SMILES: | Cn1cnc2c1cccc2c3cnc(Nc4ccc(cc4)N5CCOCC5)c(n3)C(N)=O | InChi: | InChI=1S/C23H23N7O2/c1-29-14-26-20-17(3-2-4-19(20)29)18-13-25-23(21(28-18)22(24)31)27-15-5-7-16(8-6-15)30-9-11-32-12-10-30/h2-8,13-14H,9-12H2,1H3,(H2,24,31)(H,25,27) | Definition date: | 2024-10-29 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | 6-(1-methylbenzimidazol-4-yl)-3-[(4-morpholin-4-ylphenyl)amino]pyrazine-2-carboxamide |
|
 | A1L2E | Name: | (2~{S})-2-[(2-nitro-4-phenyl-phenyl)methyl]-2~{H}-furan-5-one | Formula: | C17 H13 N O4 | SMILES: | O=C1O[CH](Cc2ccc(cc2[N](=O)=O)c3ccccc3)C=C1 | InChi: | InChI=1S/C17H13NO4/c19-17-9-8-15(22-17)10-14-7-6-13(11-16(14)18(20)21)12-4-2-1-3-5-12/h1-9,11,15H,10H2/t15-/m1/s1 | Definition date: | 2024-06-12 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | (2~{S})-2-[(2-nitro-4-phenyl-phenyl)methyl]-2~{H}-furan-5-one |
|
 | JOL | Name: | 2-chloranyl-~{N}-[[1-(4-methylphenyl)sulfonylpiperidin-4-yl]methyl]ethanamide | Formula: | C15 H21 Cl N2 O3 S | SMILES: | Cc1ccc(cc1)[S](=O)(=O)N2CCC(CC2)CNC(=O)CCl | InChi: | InChI=1S/C15H21ClN2O3S/c1-12-2-4-14(5-3-12)22(20,21)18-8-6-13(7-9-18)11-17-15(19)10-16/h2-5,13H,6-11H2,1H3,(H,17,19) | Definition date: | 2023-08-08 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | 2-chloranyl-~{N}-[[1-(4-methylphenyl)sulfonylpiperidin-4-yl]methyl]ethanamide |
|
 | JY9 | Name: | 4-[8-(aminomethyl)-2-[[5-(3-oxidanylpropyl)quinolin-8-yl]carbamoyl]quinolin-4-yl]butyl dihydrogen phosphite | Formula: | C27 H31 N4 O5 P | SMILES: | NCc1cccc2c(CCCCOP(O)O)cc(nc12)C(=O)Nc3ccc(CCCO)c4cccnc34 | InChi: | InChI=1S/C27H31N4O5P/c28-17-20-7-3-9-22-19(6-1-2-15-36-37(34)35)16-24(30-25(20)22)27(33)31-23-12-11-18(8-5-14-32)21-10-4-13-29-26(21)23/h3-4,7,9-13,16,32,34-35H,1-2,5-6,8,14-15,17,28H2,(H,31,33) | Definition date: | 2023-08-10 | Last modified: | 2025-02-14 | Release date: | 2025-02-19 | Identifier: | 4-[8-(aminomethyl)-2-[[5-(3-oxidanylpropyl)quinolin-8-yl]carbamoyl]quinolin-4-yl]butyl dihydrogen phosphite |
|